Ken Fisher started to build up the position in Catalent in Q3 2019. Since then they sold 110 Thousand shares. The investor sold all their shares in Q4 2019 and doesn't own any shares in Catalent anymore.
Novo Nordisk tapped Thermo Fisher to help make obesity drug Wegovy amid Catalent woes: Reuters aliu Wed, 08/23/2023 - 10:32
FiercePharma, 8 months agoThe Biologics Contract Development and Manufacturing Organization(CDMO) market research report added by Report Ocean, is an in-depth analysis of the latest ...
iCrowdNewswire, over 2 years agoDUBLIN, Sept. 20, 2021 /PRNewswire/ -- The "Global Contract Development and Manufacturing Organization (CDMO) Market Report and Forecast 2021-2026" report ha...
PR Newswire, over 2 years agoAccording to the new market research report "Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV)...
OpenPR, over 2 years ago